Alliance Pharma Regulatory News (APH)



Regulatory News for Alliance Pharma (APH)


Share Price: 37.25Bid: 36.50Ask: 37.00Change: 0.50 (+1.36%)Riser - Alliance Pharma
Spread: 0.50Spread as %: 1.37%Open: 36.75High: 37.00Low: 36.60Yesterday’s Close: 36.75





Notification of Major Interest in Shares

Mon, 14th May 2012 11:09

RNS Number : 2671D
Alliance Pharma PLC
14 May 2012
 

?

For Immediate Release 

14 May 2012

 

Alliance Pharma plc

 

TR-1: Notification of Major Interest in Shares

 

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:

Alliance Pharma plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):



3. Full name of person(s) subject to the
notification obligation:

Slater Investments Ltd     

4. Full name of shareholder(s)
 (if different from 3.):


5. Date of the transaction and date on
which the threshold is crossed or
reached:

11th May 2012

6. Date on which issuer notified:

13th May 2012

7. Threshold(s) that is/are crossed or
reached:

Above 4%

 

8. Notified details:

A: Voting rights attached to shares

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect

GB0031030819

9,545,000

9,545,000

10,145,000

669,042

9,475,958

0.28%

3.96%



B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date

Exercise/
Conversion Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date

Exercise/
Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 





 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

10,145,000

4.24%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

 

 


Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:



 

14. Contact name:

Ralph Baber

15. Contact telephone number:

020 7220 9460

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAESLFEKAEFF


Related Shares: Alliance Pharma (APH).




DateSourceHeadlineCategory
22-May-13 07:00RNSAGM StatementResults and Trading Reports
15-May-13 07:00RNS-RProactive Investors PresentationCompany Announcement - General
13-May-13 13:22RNSCULS Conversion and Additional ListingCompany Announcement - General
23-Apr-13 14:36RNSCULS Conversion and Additional ListingCompany Announcement - General
15-Apr-13 12:13RNSCULS Conversion and Additional ListingCompany Announcement - General
11-Apr-13 15:37RNSAnnual Report and AccountsResults and Trading Reports
08-Apr-13 15:51RNSCULS Conversion and Additional ListingCompany Announcement - General
21-Mar-13 07:00RNSPreliminary ResultsResults and Trading Reports
18-Mar-13 14:58RNSNotification of Major Interest in SharesHolding(s) in Company
08-Mar-13 14:51RNSDirector ShareholdingCompany Announcement - General
04-Mar-13 15:54RNSCULS Conversion and Additional ListingCompany Announcement - General
12-Feb-13 07:00RNSCULS ConversionCompany Announcement - General
30-Jan-13 07:00RNSNotification of Preliminary ResultsAdvance Notice of Results
22-Jan-13 17:12RNSCULS Conversion and Additional ListingCompany Announcement - General
18-Jan-13 11:50RNSExercise of Share OptionsCompany Announcement - General
17-Jan-13 09:44RNSTR-1: Notification of Major Interest in SharesHolding(s) in Company
15-Jan-13 07:00RNSPre-Close Trading UpdateCompany Announcement - General
14-Jan-13 14:13RNSExercise of Share OptionsCompany Announcement - General
10-Jan-13 16:23RNSCULS Conversion and Additional ListingCompany Announcement - General
10-Dec-12 11:33RNSCULS Conversion and Additional ListingCompany Announcement - General
07-Dec-12 09:42RNSExercise of OptionsCompany Announcement - General
03-Dec-12 12:09RNSAmended Notice - Exercise of Share OptionsCompany Announcement - General
29-Nov-12 16:13RNSExercise of Share OptionsCompany Announcement - General
12-Nov-12 17:15RNSCULS ConversionCompany Announcement - General
30-Oct-12 16:25RNSTR-1: Notification of Major Interest in SharesHolding(s) in Company
30-Oct-12 15:26RNSDirector SahreholdingCompany Announcement - General
26-Oct-12 11:30RNSDirector's DealingsDirectors' Dealings
19-Oct-12 16:37RNSShare OptionsCompany Announcement - General
19-Oct-12 16:04RNSExercise of Share OptionsCompany Announcement - General
19-Oct-12 07:00RNSAcquisitionMergers, Acquisitions and Disposals


Regulatory news is displayed end of day, each day at 19:00.
Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.